Liu et al., reported that the TIM-3 expression was significantly up-regulated in HNSCC compared to dysplasia or normal tissue [20] and preclinical investigation in in vitro mice models demonstrated that, inhibiting TIM-3 alone, insufficiently improves overall survival rates [57]. This evidence concerns the gene HAVCR2 and head and neck squamous cell carcinoma.